Bradley Canino

Stock Analyst at Stifel

(0)
# 4562
Out of 5,218 analysts
98
Total ratings
24.53%
Success rate
-14.38%
Average return
Main Sectors:
Top Industries:
22 Stocks
Name Action Price Target Current % Upside Ratings Updated
Janux Therapeutics
Maintains: Strong Buy
70 115
61.1 88.22% 2 Dec 3, 2024
Affimed
Maintains: Hold
5 4
2.13 87.79% 5 Nov 15, 2024
Syndax Pharmaceutica...
Maintains: Strong Buy
40 41
13.89 195.18% 5 Oct 14, 2024
Kura Oncology
Downgrades: Hold
26 19
9.6 97.92% 6 Oct 14, 2024
Celcuity
Maintains: Strong Buy
39 42
12.47 236.81% 4 Oct 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
25 40
17.89 123.59% 4 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
28 28
4.68 498.29% 4 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
115 135
86.68 55.75% 4 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
8.51 135.02% 1 Sep 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
5 3
1.45 106.9% 7 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
1.63 513.5% 1 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 10
3.1 222.58% 17 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
90 99
42.8 131.31% 7 Jun 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 14
4.38 219.63% 4 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
72 68
19.42 250.15% 5 May 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
40
11.77 239.85% 1 May 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
120 130
93.28 39.37% 5 Apr 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
35 55
41.98 31.01% 4 Feb 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 23
n/a n/a 5 Feb 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
2 10
2.54 293.7% 4 Jun 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
n/a n/a 1 Mar 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
50 45
n/a n/a 2 Mar 1, 2022